The carboxylic ionophore monensin inhibits active drug efflux and modulates in vitro resistance in daunorubicin resistant Ehrlich ascites tumor cells

Biochemical Pharmacology

Volumn 37, Issue 17, 1988, Pages 3305-3310

  Sehested, Maxwell ^a   Skovsgaard, Torben ^b   Roed, Henrik ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; MONENSIN; NIGERICIN;

ANIMAL CELL; ANIMAL EXPERIMENT; CELL CULTURE; CLONOGENIC ASSAY; DRUG ACCUMULATION; DRUG RESISTANCE; DRUG SENSITIVITY; DRUG TRANSPORT; EHRLICH ASCITES TUMOR CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULTRASTRUCTURE;

ANIMAL; BIOLOGICAL TRANSPORT; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; GOLGI APPARATUS; MICE; MICROSCOPY, ELECTRON; MONENSIN; NIGERICIN; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0023694852     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(88)90643-0     Document Type: Article

References (29)

1. Tumour cell resistance to anthracyclines-A review
2. Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells
3. Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells
4. The cell biology of multiple drug resistance
5. Perturbation of vesicular traffic with the carboxylic ionophore monensin
6. Development of resistance to daunomycin (NSC-82151) in Ehrlich ascites tumor
7. Inter-experiment variation and dependence on culture conditions in assaying the chemosensitivity of human small cell lung cancer cell lines
8. Tissue distribution and disposition of daunomycin (NSC-82151) in mice: Fluorometric and isotopic methods
9. Transport and binding of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumor cells
10. Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells
11. Some new aspects of the application of maximum likelihood to the calculation of the dosage response curve
12. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia
13. Cellular transport of anthracyclines by passive diffusion. Implications for drug resistance
14. Increase in non-specific adsorptive endocytosis in anthracycline and vinca alkaloid resistant Ehrlich ascites tumor cell lines
15. Increased plasma membrane traffic in daunorubicin resistant P388 leukemic cells. Effect of daunorubicin and verapamil
16. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
17. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: Effects of verapamil and other drugs
18. Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells
19. Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cells
20. Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cells
21. Lysosomotroplc agents reverse multiple drug resistance in human cancer cells
22. Effects of exogenous amines on mammalian cells, with particular reference to membrane flow
23. Biological applications of ionophores
24. Stimulation of the release of two glycoproteins from mouse 3T3 cells by growth factors and by agents that increase intralysosomal pH
25. Control of free cytoplasmic calcium by intracellular pH in rat lymphocytes
26. Regulation of Na+/H+ exchange in lymphocytes
27. Thirteen cationic ionophores: Their acute toxicity, neurobehavioral and membrane effects
28. Cytotoxicity of compounds that interfere with the regulation of intracellular pH: A potential new class of anticancer drugs
29. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants